Distinguished in Acute Myeloblastic Leukemia without Maturation

Dr. Rushang D. Patel

Oncology | Hematology
Florida Hospital Medical Group Inc
2415 N Orange Ave, 
Orlando, FL 
Accepting New Patients
17 Years of Experience
Distinguished in Acute Myeloblastic Leukemia without Maturation
Florida Hospital Medical Group Inc
2415 N Orange Ave, 
Orlando, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rushang Patel is an Oncologist and a Hematologist in Orlando, Florida. Dr. Patel has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Patel is currently accepting new patients.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in PA
Hospital Affiliations
Adventhealth Orlando
Languages Spoken
English
Hindi
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

FLORIDA HOSPITAL MEDICAL GROUP INC
2415 N Orange Ave, Orlando, FL 32804
Other Locations
FLORIDA HOSPITAL MEDICAL GROUP INC
601 E Rollins St, Orlando, FL 32803
FLORIDA HOSPITAL MEDICAL GROUP INC
2600 Westhall Ln, Maitland, FL 32751

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drugs: Pevonedistat, Venetoclax, Azacitidine
Study Phase: Phase 2
A Phase 1 / 2 Study to Evaluate the Safety and Tolerability of Adoptively Transferred Autologous T Cells in Patients With Relapsed Refractory Multiple Myeloma
A Phase 1 / 2 Study to Evaluate the Safety and Tolerability of Adoptively Transferred Autologous T Cells in Patients With Relapsed Refractory Multiple Myeloma
Enrollment Status: Suspended
Publish Date: January 16, 2024
Intervention Type: Biological
Study Drug: NEXI-002 T Cells
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: December 12, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

11 Total Publications

Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
Journal: International journal of hematology
Published: April 21, 2022
Similar Doctors
Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Juan C. Varela
Hematology | Oncology
Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Juan C. Varela
Hematology | Oncology

Orlando Health Medical Group Inc

1400 S Orange Ave, 
Orlando, FL 
 (3.3 miles away)
321-841-6600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Juan Varela is a Hematologist and an Oncologist in Orlando, Florida. Dr. Varela is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Varela is currently accepting new patients.

Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Ahmed Zakari
Hematology | Hematology Oncology | Oncology
Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Ahmed Zakari
Hematology | Hematology Oncology | Oncology

Florida Hospital Medical Group Inc

2600 Westhall Ln, 
Maitland, FL 
 (4.6 miles away)
407-200-2700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ahmed Zakari is a Hematologist and a Hematologist Oncology provider in Maitland, Florida. Dr. Zakari is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Lynch Syndrome, and Bone Marrow Transplant.

Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Shahram Mori
Hematology Oncology | Oncology | Hematology
Distinguished in Acute Myeloblastic Leukemia without Maturation
Dr. Shahram Mori
Hematology Oncology | Oncology | Hematology

Florida Hospital Medical Group Inc

2415 N Orange Ave, 
Orlando, FL 
 (0.1 miles away)
Languages Spoken:
English, Dutch, Farsi, Spanish
See accepted insurances
Accepting New Patients

Shahram Mori is a Hematologist Oncology specialist and an Oncologist in Orlando, Florida. Dr. Mori is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mori is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile